On March 8, 2021 Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, reported that members of the management team will present during a fireside chat at the H.C. Wainwright Global Life Sciences Conference, being held Mar 9-10, 2021 (Press release, Altimmune, MAR 8, 2021, View Source [SID1234576332]). Also, Altimmune’s Chief Medical Officer, Dr. Scott Harris, will be giving an oral presentation at the 2021 NASH-TAG Conference, being held March 11-13, 2021.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details on the H.C. Wainwright fireside chat presentation are as follows:

Title: H.C. Wainwright Global Life Sciences Conference

Presenters: Vipin Garg, Ph.D., Chief Executive Officer
Scot Roberts, Ph.D., Chief Scientific Officer
Scott Harris, M.D., Chief Medical Officer

Date/Time: March 9, 2021 at 7:00 am ET

A webcast link to the H.C. Wainwright fireside chat presentation will be accessible on the Events section of the Altimmune website.

Details on the NASH-TAG 2021 presentation by Dr. Scott Harris are as follows:

Title: Dual GLP-1 Agonists in the Treatment of Metabolic
& Liver Dysfunction in NASH

Presenter: Scott Harris M.D., Chief Medical Officer

Date/Time: March 13, 2021 at 9:30 pm ET

A copy of the presentation materials will be accessible on the Events section of the Altimmune website.